The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Primary localized gastrointestinal stromal tumors (GIST) of the duodenum: Final results of a French Sarcoma Group (FSG) retrospective review of 110 patients (pts).
Thanh Khoa Huynh
No relevant relationships to disclose
Philippe A Cassier
No relevant relationships to disclose
Jean Baptiste Bachet
Consultant or Advisory Role - Roche
Honoraria - Amgen; Merck Serono
Research Funding - Roche
Eveline Boucher
Honoraria - Merck Serono
Olivier Bouche
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Axel Le Cesne
Honoraria - Novartis; Pfizer; PharmaMar
Bruno Landi
Honoraria - Novartis; Pfizer
Julien Mancini
No relevant relationships to disclose
Frederic Marchal
Honoraria - GlaxoSmithKline; Roche/Genentech; Sanofi
Jacques-Olivier Bay
No relevant relationships to disclose
François Bertucci
Honoraria - Roche
Jean-Philippe Spano
Honoraria - Amgen; Cephalon; GlaxoSmithKline; LEO Pharma; Lilly; Merck; Roche; Sanofi
Antoine Italiano
No relevant relationships to disclose
Olivier Collard
No relevant relationships to disclose
Loic Chaigneau
Honoraria - PharmaMar
Nicolas Isambert
Honoraria - PharmaMar
Valerie Lebrun-Ly
No relevant relationships to disclose
Jean-Yves Blay
Honoraria - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Research Funding - GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche
Florence Duffaud
Honoraria - Merck; Novartis; Pfizer; PharmaMar; Roche; Roche